Sir Steve Jackson
Founding Partner at Ahren Innovation Capital
About
Founding partner and originator of the cancer drug Olaparib/Lynparza and founder of Adrestia Therapeutics with Ahren. Cambridge professor, DNA-repair expert and Fellow of the Royal Society.
Colleagues at Ahren Innovation Capital
Alice Newcombe-Ellis
Founding and General Partner at Ahren Innovation Capital
Andy Parker
Founding Partner at Ahren Innovation Capital
Anuj Nanwani
Principal at Ahren Innovation Capital
David Novak
Advisor at Ahren Innovation Capital
Janusz Marecki
AI Partner at Ahren Innovation Capital
Joanna Green
Principal at Ahren Innovation Capital
Lord Martin Rees
Founding Partner at Ahren Innovation Capital
Oliver Hedaux
Principal at Ahren Innovation Capital